Adol-Sinus – 24 Caplets
11
Adol-Sinus, 24 caplets for fast relief from nasal congestion, fever, and pain. Effective and fast-acting formula.
Out of stock
SKU:
a2972
Category: Medical care
Description
Adol-Sinus – 24 Caplets provides fast relief from nasal congestion, fever, and pain. Fast relief from congestion, headaches, and fever. Non-drowsy formula for daytime use. Suitable for adults and adolescents (12+ years old). Easy-to-swallow caplets.
Usage Instructions for Adol-Sinus: Adults & elderly: 1-2 caplets up to 3 times daily (max 6 caplets per day). Adolescents (16-18 years): 2 caplets up to 3 times daily (max 6 caplets per day). Adolescents (12-15 years): 1 caplet up to 3 times daily (max 3 caplets per day). Leave at least 4 hours between doses. Do not exceed the recommended dosage.
Ingredients of Adol-Sinus: Paracetamol (325 mg): Pain reliever and fever reducer. Pseudoephedrine HCL (30 mg): Decongestant.
#AdolSinus #PainRelief #FeverReducer #NasalDecongestant #Cold #Flu #Health #Healthcare #Medicine #SaudiArabia
Reviews (0)
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “Adol-Sinus – 24 Caplets” Cancel reply
Skin exfoliation products
Skin moisturizing products
Skin cleansers
Sun protection products
Skin whitening products
Skin serums
Korean skin care products
Skin masks
Natural skin care products
Shampoo
Hair cream bath and masks
Hair styling products
Hair oils and serums
Hair dyes
Natural hair products
Baby strollers
Baby toys
Baby carriers
Car seats
Baby walkers
Baby rockers
Baby beds
Baby milk
Baby food
Baby feeding supplies
Baby bottles
Pacifiers
Teethers
Baby hygiene care
Skin care for babies
Diapers
Perfumes for babies
Women’s perfumes
Men’s perfumes
Unisex perfumes
Oriental perfumes
Luxury perfumes
Hair perfumes
Deodorants
Body and shower care
Women’s care products
Men’s care products
Sexual health
Lipsticks
Eye Makeup
Face Makeup
False nails and lashes
Contact Lenses

Reviews
Clear filtersThere are no reviews yet.